Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Leger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Microbiology Spectrum|June 18, 2015
Antibody EngineeringKin-Ming Lo, Olivier Leger, Björn Hock
Biotechnology and Bioengineering|October 26, 2012
IL-17F co-expression improves cell growth characteristics and enhances recombinant protein production during CHO cell line engineeringMathias Contie, Olivier Leger, Nicolas Fouque, et al.
International Journal of Cancer|September 24, 2004
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenograftsLiliane Goetsch, Alexandra Gonzalez, Olivier Leger, et al.
International Orthopaedics|June 24, 2022
Use of a locking stem for reverse shoulder arthroplasty is a rare but reliable optionGeoffroy Nourissat, Simon Corsia, Uma Srikumaran, et al.
Journal of Shoulder and Elbow Surgery|March 11, 2023
Stemless reverse shoulder arthroplasty: clinical and radiologic outcomes with minimum 2 years' follow-upMarko Nabergoj, Alexandre Lädermann, Thierry Authom, et al.
The Journal of Biological Chemistry|October 9, 2007
Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1Irene Dunn-Siegrist, Olivier Leger, Bruno Daubeuf, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2013
Chemokine receptor antagonist developmentAlexandre Garin, Zoë Johnson, Aurelie Hermant, et al.
The Journal of Biological Chemistry|April 17, 2014
Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tetheringLimin Shang, Bruno Daubeuf, Martha Triantafilou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Microbiology Spectrum|June 18, 2015
Antibody EngineeringKin-Ming Lo, Olivier Leger, Björn Hock
Biotechnology and Bioengineering|October 26, 2012
IL-17F co-expression improves cell growth characteristics and enhances recombinant protein production during CHO cell line engineeringMathias Contie, Olivier Leger, Nicolas Fouque, et al.
International Journal of Cancer|September 24, 2004
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenograftsLiliane Goetsch, Alexandra Gonzalez, Olivier Leger, et al.
International Orthopaedics|June 24, 2022
Use of a locking stem for reverse shoulder arthroplasty is a rare but reliable optionGeoffroy Nourissat, Simon Corsia, Uma Srikumaran, et al.
Journal of Shoulder and Elbow Surgery|March 11, 2023
Stemless reverse shoulder arthroplasty: clinical and radiologic outcomes with minimum 2 years' follow-upMarko Nabergoj, Alexandre Lädermann, Thierry Authom, et al.
The Journal of Biological Chemistry|October 9, 2007
Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1Irene Dunn-Siegrist, Olivier Leger, Bruno Daubeuf, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2013
Chemokine receptor antagonist developmentAlexandre Garin, Zoë Johnson, Aurelie Hermant, et al.
The Journal of Biological Chemistry|April 17, 2014
Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tetheringLimin Shang, Bruno Daubeuf, Martha Triantafilou, et al.
Pageof 1